Literature DB >> 28875499

The intestinal microbiota determines the colitis-inducing potential of T-bet-deficient Th cells in mice.

Jakob Zimmermann1,2, Pawel Durek1, Anja A Kühl3, Florian Schattenberg4, Patrick Maschmeyer1, Francesco Siracusa1, Katrin Lehmann1, Kerstin Westendorf1, Melanie Weber1, René Riedel1,5, Susann Müller4, Andreas Radbruch1, Hyun-Dong Chang1.   

Abstract

Conflicting evidence has been provided as to whether induction of intestinal inflammation by adoptive transfer of naïve T cells into Rag-/- mice requires expression of the transcription factor T-bet by the T cells. Here, we formally show that the intestinal microbiota composition of the Rag-/- recipient determines whether or not T-bet-deficient Th cells can induce colitis and we have resolved the differences of the two microbiomes, permissive or non-permissive to T-bet-independent colitis. Our data highlight the dominance of the microbiota over particular T cell differentiation programs in the pathogenesis of chronic intestinal inflammation.
© 2017 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Inflammatory bowel disease; Microbiota; T cell transfer colitis; T helper cells; T-bet

Mesh:

Substances:

Year:  2017        PMID: 28875499      PMCID: PMC5813160          DOI: 10.1002/eji.201747100

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


Introduction

Crohn's disease – a chronic inflammatory disorder of the gastrointestinal tract – is characterized by the accumulation of proinflammatory T helper (Th) 1, Th17, and bifunctional Th1/17 cells in the intestinal mucosa 1. However, the relative contribution of the various T cell subsets to disease initiation and perpetuation has remained elusive. In mice, intestinal inflammation can be induced by transfer of naïve CD45RBhi Th cells into immunodeficient Rag −/− mice 2. Similarly to Crohn's disease, transferred T cells differentiate into Th1, Th17, and hybrid Th1/17 cells and cause inflammation by recruiting and activating myeloid effector cells 3, 4, 5. However, conflicting evidence has been provided as to whether induction of colitis is dependent on expression of the Th1 lineage‐determining transcription factor T‐bet by the Th cells 5, 6, 7, 8, 9. Here we show that the recipient's intestinal microbiota determines whether T‐bet‐deficient Th cells can induce colitis.

Results and discussion

Recipient hygiene status determines colitis‐inducing potential of T‐bet‐deficient Th cells

When transferring CD4+CD45RBhiCD25− Th cells into Rag1 −/− recipients, derived from the Jackson Laboratory (USA) and bred at a Charles River facility (Sulzfeld, Germany), WT but not T‐bet‐deficient Th cells induced colitis (Fig. 1A, B ‘T‐bet‐dependent’ Rag1 −/−). When instead Rag1 −/− recipients were transplanted with fecal microbiota from the DRFZ Berlin animal facility prior to T cell transfer, T‐bet‐deficient Th cells induced colitis comparable to WT Th cells (Fig. 1A, B ‘T‐bet‐independent’ Rag1 −/− from ref. 5). In ‘T‐bet‐dependent’ Rag1 −/− recipients, absolute numbers of T‐bet‐deficient Th cells were 8‐times lower compared with WT Th cells (Fig. 1C – black symbols). The frequency of Th cells expressing the cell cycle marker Ki‐67 was significantly higher for WT compared with T‐bet‐deficient Th cells (Fig. 1D – black symbols). These observations contrast the results obtained with ‘T‐bet‐independent’ Rag1 −/− recipients in which absolute numbers of T‐bet‐deficient Th cells reached approximately 50% of the WT level and Ki‐67 expression was similar between WT and T‐bet‐deficient Th cells (Fig. 1C, D – gray symbols, from ref. 5).
Figure 1

The microbiota determines the colitis‐inducing potential of T‐bet‐deficient Th cells. CD4+CD45RBhiCD25− WT or Tbx21 −/− CD4 T cells were transferred into Rag1 recipients directly from Charles River (‘T‐bet‐dependent’ Rag1 −/−) or after colonization with fecal microbiota from the DRFZ animal colony (‘T‐bet‐independent’ Rag1 −/−). (A) Representative hematoxylin‐eosin staining of the colon on day 40–44 (‘T‐bet‐dependent’ Rag1 −/−) and day 18 (‘T‐bet‐independent’ Rag1 −/−), bars are 100 μm. (B) Colon histopathology scores for n = 13 ‘T‐bet‐dependent’ recipients per group pooled from three experiments and n = 8 ‘T‐bet‐independent’ Rag1 −/− recipients per group pooled from two experiments. (C) Absolute number of colonic CD4+ Th cells for n = 12‐13 ‘T‐bet‐dependent’ recipients per group pooled from three experiments and n = 15 ‘T‐bet‐independent’ Rag1 −/− recipients per group pooled from four experiments (full gating strategy in Supporting Information Fig. 1). (D) Frequency of Ki‐67‐expressing colonic CD4+ Th cells for n = 12‐13 mice per group each pooled from three experiments. (E, G) Expression of T‐bet/ROR‐γt and IFN‐γ/IL‐17A by colonic CD4+ Th cells from ‘T‐bet‐dependent’ Rag1 −/− recipients. (F, H) Frequency of ROR‐γt and cytokine‐expressing colonic CD4+ Th cells from n = 11‐13 ‘T‐bet‐dependent’ recipients pooled from three experiments and n = 8 ‘T‐bet‐independent’ Rag1 −/− recipients pooled from two experiments. (B‐D, F, H) Data are shown as ±SEM with * p<0.05, ** p<0.01, and *** p<0.001 by one‐way ANOVA and Newman–Keuls test. Data for ‘T‐bet‐independent’ Rag1 −/− mice are from 5.

The microbiota determines the colitis‐inducing potential of T‐bet‐deficient Th cells. CD4+CD45RBhiCD25− WT or Tbx21 −/− CD4 T cells were transferred into Rag1 recipients directly from Charles River (‘T‐bet‐dependent’ Rag1 −/−) or after colonization with fecal microbiota from the DRFZ animal colony (‘T‐bet‐independent’ Rag1 −/−). (A) Representative hematoxylineosin staining of the colon on day 40–44 (‘T‐bet‐dependent’ Rag1 −/−) and day 18 (‘T‐bet‐independent’ Rag1 −/−), bars are 100 μm. (B) Colon histopathology scores for n = 13 ‘T‐bet‐dependent’ recipients per group pooled from three experiments and n = 8 ‘T‐bet‐independent’ Rag1 −/− recipients per group pooled from two experiments. (C) Absolute number of colonic CD4+ Th cells for n = 12‐13 ‘T‐bet‐dependent’ recipients per group pooled from three experiments and n = 15 ‘T‐bet‐independent’ Rag1 −/− recipients per group pooled from four experiments (full gating strategy in Supporting Information Fig. 1). (D) Frequency of Ki‐67‐expressing colonic CD4+ Th cells for n = 12‐13 mice per group each pooled from three experiments. (E, G) Expression of T‐bet/ROR‐γt and IFN‐γ/IL‐17A by colonic CD4+ Th cells from ‘T‐bet‐dependent’ Rag1 −/− recipients. (F, H) Frequency of ROR‐γt and cytokine‐expressing colonic CD4+ Th cells from n = 11‐13 ‘T‐bet‐dependent’ recipients pooled from three experiments and n = 8 ‘T‐bet‐independent’ Rag1 −/− recipients pooled from two experiments. (B‐D, F, H) Data are shown as ±SEM with * p<0.05, ** p<0.01, and *** p<0.001 by one‐way ANOVA and Newman–Keuls test. Data for ‘T‐bet‐independent’ Rag1 −/− mice are from 5. In ‘T‐bet‐dependent’ Rag1 −/− mice, the frequency of T‐bet‐deficient ROR‐γt‐expressing Th cells was strongly increased compared with WT but remained below the frequency of ROR‐γt+ T‐bet‐deficient Th cells in ‘T‐bet‐independent’ Rag1 −/− recipients (Fig. 1E, F). In both types of recipients, T‐bet‐deficient Th cells had decreased IFN‐γ and increased IL‐17A expression compared with WT Th cells (Fig. 1G, H). ‘T‐bet‐dependent’ Rag1 −/− recipients had reduced frequencies of IFN‐γ+IL‐17A+ double‐positive T‐bet‐deficient Th cells when compared with ‘T‐bet‐independent’ Rag1 −/− recipients (Fig. 1H). Relative frequencies of Foxp3+ regulatory T cells were increased in the colon of ‘T‐bet‐dependent’ Rag1 −/− recipients after transfer of T‐bet‐deficient compared with WT Th cells. However, absolute numbers of Foxp3+ regulatory T cells remained similar (Supporting Information Fig. 2). We have previously described that T‐bet‐deficient Th cells orchestrate a different inflammatory reaction compared with WT with reduced numbers of monocytes and macrophages but increased numbers of eosinophils in the colon of ‘T‐bet‐independent’ Rag1 −/− recipients 5. In ‘T‐bet‐dependent’ Rag1 −/− recipients, T‐bet‐deficient Th cells induced colitis with strongly reduced numbers of monocytes, macrophages, and neutrophils but similar numbers of eosinophils compared with WT Th cells (Supporting Information Fig. 3).

Microbiome differences of mice permissive or non‐permissive to T‐bet‐independent colitis

The fecal microbiota composition of Rag1 −/− mice enabling ‘T‐bet‐dependent’ versus ‘T‐bet‐independent’ colitis was substantially different, both before and after transfer of WT T cells (Fig. 2, Supporting Information Figs. 4–7). Linear discriminant analysis effect size (LEfSe) 10 and random forest 11 analysis identified several genera from three major phyla (Bacteroidetes, Firmicutes, and Proteobacteria) that distinguished ‘T‐bet‐dependent’ from ‘T‐bet‐independent’ microbiomes. Whereas ‘T‐bet‐dependent’ Rag −/− recipients were specifically enriched in Marvinbryantia and Clostridium cluster XIVb, ‘T‐bet‐independent’ Rag −/− mice revealed an increase in many different taxa including those previously implicated in intestinal inflammation such as Prevotella and Bacteroides 12, 13 (Fig. 2A and C). Notably, colitis resulted in reduced alpha diversity selectively in ‘T‐bet‐independent’ Rag1 −/− recipients (Supporting Information Fig. 4). Among the taxa enriched in ‘T‐bet‐independent’ Rag −/− recipients, we identified Helicobacter species including Helicobacter hepaticus (Fig. 2A–D, Supporting Information Figs. 5–7) that have previously been shown to drive colitis 14. However, T‐bet‐deficient Th cells induced colitis comparable with WT in Rag1 −/− recipients tested negative for Helicobacter species by PCR (Supporting Information Fig. 8). In Helicobacter‐negative recipients, colitis development was delayed to 38–40 days compared with 18 days in Helicobacter‐positive mice (data not shown). Segmented filamentous bacteria (SFB), which have also been implicated in colitis induction 15, were present in ‘T‐bet‐independent’ but not in ‘T‐bet‐dependent’ Rag1 −/− recipients as detected by conventional PCR from feces (data not shown). Their presence correlated with increased colonic frequencies of ROR‐γt+ T cells in ‘T‐bet‐independent’ Rag1 −/− recipients (Fig. 1F). However, whether SFB determine susceptibility to colitis induced by T‐bet‐deficient Th cells remains elusive and seems unlikely given our previous observations of a protective function of IL‐17 in colitis induced by both WT and T‐bet‐deficient Th cells 5.
Figure 2

The microbiomes of ‘T‐bet‐dependent’ and ‘T‐bet‐independent’ Rag1 −/− recipients. Fecal microbiomes of mice from Fig. 1 were determined by 16S rDNA sequencing for n = 5 ‘T‐bet‐dependent’ Rag1 −/− mice and n = 3 ‘T‐bet‐independent’ Rag1 −/− mice from reference 29 before (‘Healthy’) and after (‘Colitis’) transfer of WT Th cells (‘T‐bet‐dependent’ Rag1 −/−: day 40, ‘T‐bet‐independent’ Rag1 −/−: day 12–15). (A and C) Linear discriminant analysis (LDA) scores of taxa significantly enriched in ‘T‐bet‐dependent’ (green) or ‘T‐bet‐independent’ (red) microbiomes (A ‐ healthy, C ‐ colitis). Taxa with a relative abundance of at least 1% in at least one sample were included. LDA scores ≥ 2 were considered significant. (B and D) Cladograms showing the phylogenetic relationship among the analyzed taxa at the kingdom, phylum, class, order, and family level with dot size representing the mean abundance of the taxa. (E) PICRUSt analysis depicting KEGG pathways significantly enriched in healthy ‘T‐bet‐dependent’ (green) or ‘T‐bet‐independent’ (red) microbiomes with dot size representing the mean ortholog count of the pathway. LDA scores ≥ 2 were considered significant. Data shown are from each one experiment with n = 3 mice (‘T‐bet‐independent’) and n = 5 mice (‘T‐bet‐dependent’) per group.

The microbiomes of ‘T‐bet‐dependent’ and ‘T‐bet‐independent’ Rag1 −/− recipients. Fecal microbiomes of mice from Fig. 1 were determined by 16S rDNA sequencing for n = 5 ‘T‐bet‐dependent’ Rag1 −/− mice and n = 3 ‘T‐bet‐independent’ Rag1 −/− mice from reference 29 before (‘Healthy’) and after (‘Colitis’) transfer of WT Th cells (‘T‐bet‐dependent’ Rag1 −/−: day 40, ‘T‐bet‐independent’ Rag1 −/−: day 12–15). (A and C) Linear discriminant analysis (LDA) scores of taxa significantly enriched in ‘T‐bet‐dependent’ (green) or ‘T‐bet‐independent’ (red) microbiomes (A ‐ healthy, C ‐ colitis). Taxa with a relative abundance of at least 1% in at least one sample were included. LDA scores ≥ 2 were considered significant. (B and D) Cladograms showing the phylogenetic relationship among the analyzed taxa at the kingdom, phylum, class, order, and family level with dot size representing the mean abundance of the taxa. (E) PICRUSt analysis depicting KEGG pathways significantly enriched in healthy ‘T‐bet‐dependent’ (green) or ‘T‐bet‐independent’ (red) microbiomes with dot size representing the mean ortholog count of the pathway. LDA scores ≥ 2 were considered significant. Data shown are from each one experiment with n = 3 mice (‘T‐bet‐independent’) and n = 5 mice (‘T‐bet‐dependent’) per group. Based on the significant differences in microbiota composition between ‘T‐bet‐dependent’ and ‘T‐bet‐independent’ Rag1 −/− recipients, we analyzed possible functional differences of the two microbiomes using PICRUSt (phylogenetic investigation of communities by reconstruction of unobserved states) 16. The two microbiomes were predicted to differ strongly in the representation of metabolic pathways (Fig. 2E). Thus, differential susceptibility to colitis induced by T‐bet‐deficient Th cells could not only be mediated by direct bacteria ‐ host interactions 15, 17, 18, but also by bacterial metabolites 19, 20, 21. Overall, it remains to be determined which bacterial taxa differentially activate T‐bet‐sufficient or T‐bet‐deficient Th cells to induce colitis and how they do it, e.g. by microbiota‐derived metabolites or direct interaction with the host. Collectively, our data show that the requirement for T‐bet for Th cell colitogenicity depends on the composition of the intestinal microbiota of the Rag1 −/− recipients. In non‐permissive Rag1 −/− recipients T‐bet‐deficient Th cells had reduced proliferative activity and diminished differentiation towards IFN‐γ+IL‐17A+ Th cells. It has been shown previously that microbiota‐induced T cell proliferation is required for colitis development in this model 22. T‐bet expression seems to overcome the reduced T cell stimulation by certain bacteria which supports a previously described role for T‐bet in enhancing T cell proliferation 23. Moreover, the permissive microbiota apparently promotes differentiation of T‐bet‐deficient Th cells into IFN‐γ+IL‐17A+ Th cells, offering another possible mechanism why T‐bet‐deficient Th cells fail to induce colitis in ‘T‐bet‐dependent’ recipients. IFN‐γ+IL‐17A+ Th1/17 cells have been described as proinflammatory drivers of T cell transfer colitis before 3, 9. Our own previous data, however, demonstrate that neither IFN‐γ nor IL‐17A expression by the transferred Th cells is critical for colitis development, but rather the expression of chemokines recruiting pro‐inflammatory myeloid cells by the Th cells 5. How this is controlled by the microbiota is still unclear. Recently, it has emerged that the susceptibility to inflammatory diseases is not determined by the host genome alone but by its interaction with the microbiome 24. Helicobacter hepaticus and Bacteroides for example were shown to induce intestinal inflammation only in hosts that are genetically susceptible 13, 25. Reciprocally, our results show that genetic deficiency for T‐bet in T cells alleviates colitis only in the context of a certain microbiota. Thus, host genome – microbiota interactions not only explain variability in disease susceptibility, but likely also the discrepancies in the results of genetic studies in mice – as we illustrate here for the T‐bet requirement in T cell transfer colitis. Our findings suggest that IBD may comprise many distinct pathologies that depend on the patient's genetic predisposition and microbiota composition. In this scenario, T‐bet‐dependent Th1 cells likely represent one out of many disease‐driving T cell subpopulations resulting in a distinct IBD subgroup. In support of this, a recent study revealed that IBD comprises a continuous spectrum of diseases rather than just Crohn's disease and ulcerative colitis 26. Specifically, colonic Crohn's disease was found to be as different from ileal Crohn's disease as it is from ulcerative colitis again suggesting an important role for the microbiota – which is different between ileum and colon – in shaping these pathologies. Finally, the heterogeneous response of IBD patients to various biologicals targeting IFN‐γ, TNF, IL‐12/23, and integrin α4β7, points to diverse inflammatory mechanisms being at work 27.

Concluding remarks

Our study explains the disparate results regarding the requirement for T‐bet for the induction of CD4+ T cell‐mediated intestinal inflammation and highlights that the composition of the intestinal microbiota can determine the molecular pathways that lead to chronic inflammation. These findings not only suggest that human IBD pathophysiology may be highly individual and microbiota‐dependent but also again stress the importance of standardizing the microbiota in animal experiments.

Materials and methods

Mice

C57BL6/J, Rag1 −/−, and Tbx21 −/− mice were housed and bred under specific pathogen‐free conditions in individually ventilated cages. Rag1 −/− mice were initially purchased from the Jackson Laboratory (USA) and then bred at Charles River (Sulzfeld, Germany). Absence (in ‘T‐bet‐dependent’ Rag1 −/− mice) or presence (in ‘T‐bet‐independent’ Rag1 −/− mice) of Helicobacter species (H. spp) and segmented filamentous bacteria (SFB) was confirmed at the beginning and at the end of the experiment by PCR from fecal DNA with the following primer pairs: H. spp Fw: 5′‐ctatgacgggtatccggc‐3′, Rv: 5′‐attccacctacctctccca‐3′, SFB Fw: 5′‐gacgctgaggcatgagagcat‐3′, Rv: 5′‐gacggcacggattgttattca‐3′. T‐bet‐independent Rag1 −/− mice were colonized by oral gavage with a fecal bacterial suspension tested positive for H. spp and SFB at least 2 weeks prior to T cell transfer 5. Mice were handled in accordance with good animal practice as defined by the German animal welfare bodies. All experiments were approved by the regulatory office „Landesamt für Gesundheit und Soziales“ in Berlin, Germany under the permit number G0300/11.

Colitis induction

Colitis was induced as published before 2. Briefly, CD4+ T cells from spleen and lymph nodes of WT or Tbx21 −/− C57BL/6J donors were purified by high‐gradient magnetic cell sorting (MACS) using mouse CD4 direct beads (L3T4, Miltenyi Biotec). Viable CD4+CD45RBhiCD25− cells were isolated by fluorescence‐activated cell sorting (FACS) with a FACSAria I (BD Biosciences). 4 × 105 cells were injected i.v. into each Rag1 −/− recipient. Different experimental groups (recipients of WT and Tbx21 −/− Th cells) were cohoused in the same cages. Mice were sacrificed about 6 weeks after transfer.

Histology

Colons were fixed in 4% paraformaldehyde at 4°C in the “Swiss roll” formation overnight. After washing with PBS and dewatering, colons were embedded in paraffin. Sections were stained with hematoxylin and eosin. Colitis histopathology was scored in a blinded fashion as published before 5.

Isolation of lamina propria leukocytes

Lamina propria leukocytes (LPL) were isolated from colon and small intestine as described before 5. In brief, intestines were freed from fat, opened longitudinally and washed with PBS. The epithelial layer was stripped off in two rounds of incubation in calcium/magnesium‐free HBSS with 5 mM EDTA and 10 mM HEPES for 20 min at 37 °C. To obtain a single cell suspension of the mucosa, intestines were minced into small pieces and incubated 3 times for 20 min at 37 °C with 0.5 mg/ml Collagenase D (Roche), 0.5 mg/ml DNase I (Sigma Aldrich) and 0.05 U/ml Dispase (BD Biosciences). For small intestines, LPL were separated from debris by centrifugation over a Percoll gradient.

Restimulation and flow cytometry

For intracellular cytokine staining, cells were restimulated with 10 ng/mL PMA and 1 μg/mL ionomycin in IMDM medium, containing 10% FCS at 5 × 106‐1 × 107 cells/mL for a total of 4 h 28. After 1 h, brefeldin A was added to a final concentration of 5 μg/mL. Cells were stained with a fixable live/dead discrimination dye for 20 min on ice, fixed with Cytofix/Cytoperm buffer (BD) and stained in 0.5% w/v Saponin for 20 min on ice. For transcription factor staining, cells were stained with the fixable live/dead discrimination dye directly ex vivo, fixed with the Foxp3 staining buffer kit (eBioscience) for 1 h on ice and stained in the 1× perm buffer from the Foxp3 staining buffer kit for 1 h on ice. Samples were acquired on an MACS Quant (Miltenyi Biotec). The following antibodies and reagents were used (clone, supplier): CD3ε APC‐eFluor® 780 (145‐2C11, eBioscience), CD4 Pe‐Cy7 (RM4‐5, eBioscience), CD45RB PE (16A, BD Biosciences), CD25 APC (PC61, Biolegend), IFN‐γ PerCP‐Cy5.5 (XMG1.2, eBioscience), IL‐17A FITC (TC11‐18H10.1, Biolegend), ROR‐γt PE (Q31‐378, BD Biosciences), T‐bet Alexa Fluor® 647 (4B10, Biolegend).

16S rDNA sequencing of fecal bacteria

DNA isolation and 16S sequencing were performed as described previously 29. Raw sequence data were deposited at the NCBI Sequence Read Archive (SRA) under the accession number SRP078391 (T‐bet‐independent recipients: SRP069847 from Ref. 5). Combined reads from both projects were classified using the ribosomal database project “Classifier” tool with a confidence cutoff of 50% 30. The copy number‐adjusted counts were agglomerated to bacterial families and genera and plotted as ratio to the total counts of the bacterial kingdom. For the calculation of Shannon index and rarefaction analysis, the RDP pipeline was used including the tools “Aligner”, “Complete Linkage Clustering”, “Shannon & Chao1 index”, and “Rarefaction” using 5000 reads per sample 31. To estimate beta diversity, Bray‐Curtis distances were computed by the ‘vegan’ package after resampling of the samples to equal sizes 32. Principal Coordinates Analysis (PCoA) was performed by RDPutils using the Bray‐Curtis distance 33. Linear discriminant analysis effect size 10 and Random Forest (RF) 11 approaches were used to identify the taxa responsible for the differences between ‘T‐bet‐dependent’ and ‘T‐bet‐independent’ Rag1 −/− mice before and after colitis induction 11. Copy number‐adjusted bacterial rDNA counts were agglomerated at the genus level and normalized to total bacterial counts. LEfSe was applied with default parameter settings based on bacterial frequencies scaled by 1M without further normalization. To account for the highly diverse compositions of microbiomes between ‘T‐bet‐dependent’ and ‘T‐bet‐independent’ Rag1 −/− mice solely taxa with frequencies above 0.1% or 1% in at least one investigated sample were considered. For the significance a LDA threshold > 2 was used. The RFs were constructed based on the frequencies of classified taxa at genus level before and after colitis induction using 1M trees in each RF. To account for the highly diverse compositions three randomly chosen taxa were used in each split and solely taxa with read frequencies above 0.1 or 1% in all samples of at least one of the groups were considered. The impact was measured by the mean decrease of the Gini coefficient as well as the estimated accuracy of the prediction after perturbation of the frequencies for each considered taxon. Differences in the abundance of metabolic pathways were determined using PICRUSt 16 and LEfSe. OTU tables for PICRUSt were prepared with QIIME 34 by assigning taxonomies based on Greengenes reference OTUs 13–5 35 to raw sequences with the RDP method. Reference OTUs were picked with a similarity of 0.97. Subsequently, OTU‐tables were down‐sampled to the smallest library size, adjusted to copy numbers and subjected to KEGG‐ortholog prediction by PICRUSt. Orthologs involved in metabolism were further normalized to 1M counts and summarized in KEGG categories. LEfSe abundance tables were constructed by KEGG level 1–3 categories and redundantly augmented by the normalized ortholog counts. LEfSe was applied with default parameter settings without further normalization.

Data presentation and statistical evaluation

Graphs depict mean ± SEM unless stated otherwise. Statistical analysis was done with Graph pad prism version 5 using a one‐way ANOVA followed by the post‐test indicated in the figure legend. For the comparison of two groups, the Student's t‐test for independent samples or the Mann–Whitney‐U‐test for independent samples was used depending on the group sizes.

Conflict of interest

The authors declare no commercial or financial conflict of interest. Cluster of Differentiation Inflammatory bowel disease Interferon gamma Interleukin Linear discriminant analysis effect size Phylogenetic investigation of communities by reconstruction of unobserved states Recombination‐activating gene Retinoic acid receptor‐related orphan receptor gamma t Segmented filamentous bacteria T‐box expressed in T cells T helper cell Tumor necrosis factor wild type Supporting Information Click here for additional data file. Peer review correspondence Click here for additional data file.
  32 in total

1.  Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.

Authors:  T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

2.  Accounting for reciprocal host-microbiome interactions in experimental science.

Authors:  Thaddeus S Stappenbeck; Herbert W Virgin
Journal:  Nature       Date:  2016-06-09       Impact factor: 49.962

3.  The role of the Th1 transcription factor T-bet in a mouse model of immune-mediated bone-marrow failure.

Authors:  Yong Tang; Marie J Desierto; Jichun Chen; Neal S Young
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

4.  A microbial symbiosis factor prevents intestinal inflammatory disease.

Authors:  Sarkis K Mazmanian; June L Round; Dennis L Kasper
Journal:  Nature       Date:  2008-05-29       Impact factor: 49.962

5.  Interleukin-23 drives intestinal inflammation through direct activity on T cells.

Authors:  Philip P Ahern; Chris Schiering; Sofia Buonocore; Mandy J McGeachy; Dan J Cua; Kevin J Maloy; Fiona Powrie
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

6.  Metagenomic biomarker discovery and explanation.

Authors:  Nicola Segata; Jacques Izard; Levi Waldron; Dirk Gevers; Larisa Miropolsky; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

7.  High-resolution microbiota flow cytometry reveals dynamic colitis-associated changes in fecal bacterial composition.

Authors:  Jakob Zimmermann; Thomas Hübschmann; Florian Schattenberg; Joachim Schumann; Pawel Durek; René Riedel; Marie Friedrich; Rainer Glauben; Britta Siegmund; Andreas Radbruch; Susann Müller; Hyun-Dong Chang
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

8.  Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4.

Authors:  M Refik Gökmen; Rong Dong; Aditi Kanhere; Nick Powell; Esperanza Perucha; Ian Jackson; Jane K Howard; Maria Hernandez-Fuentes; Richard G Jenner; Graham M Lord
Journal:  J Immunol       Date:  2013-11-18       Impact factor: 5.422

9.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

10.  Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.

Authors:  Isabelle Cleynen; Gabrielle Boucher; Luke Jostins; L Philip Schumm; Sebastian Zeissig; Tariq Ahmad; Vibeke Andersen; Jane M Andrews; Vito Annese; Stephan Brand; Steven R Brant; Judy H Cho; Mark J Daly; Marla Dubinsky; Richard H Duerr; Lynnette R Ferguson; Andre Franke; Richard B Gearry; Philippe Goyette; Hakon Hakonarson; Jonas Halfvarson; Johannes R Hov; Hailang Huang; Nicholas A Kennedy; Limas Kupcinskas; Ian C Lawrance; James C Lee; Jack Satsangi; Stephan Schreiber; Emilie Théâtre; Andrea E van der Meulen-de Jong; Rinse K Weersma; David C Wilson; Miles Parkes; Severine Vermeire; John D Rioux; John Mansfield; Mark S Silverberg; Graham Radford-Smith; Dermot P B McGovern; Jeffrey C Barrett; Charlie W Lees
Journal:  Lancet       Date:  2015-10-18       Impact factor: 202.731

View more
  3 in total

Review 1.  Epigenetic regulation of T helper cells and intestinal pathogenicity.

Authors:  Yuya Hagihara; Yusuke Yoshimatsu; Yohei Mikami; Yoshiaki Takada; Shinta Mizuno; Takanori Kanai
Journal:  Semin Immunopathol       Date:  2019-03-19       Impact factor: 9.623

2.  Murine T-Cell Transfer Colitis as a Model for Inflammatory Bowel Disease.

Authors:  Patrick Maschmeyer; Jakob Zimmermann; Anja Andrea Kühl
Journal:  Methods Mol Biol       Date:  2021

Review 3.  Immunological memory in rheumatic inflammation - a roadblock to tolerance induction.

Authors:  Patrick Maschmeyer; Hyun-Dong Chang; Qingyu Cheng; Mir-Farzin Mashreghi; Falk Hiepe; Tobias Alexander; Andreas Radbruch
Journal:  Nat Rev Rheumatol       Date:  2021-04-06       Impact factor: 20.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.